NASDAQ:BLPH
Bellerophon Therapeutics Stock Price (Quote)
$0.398
+0.0166 (+4.36%)
At Close: Sep 29, 2023
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.370 | $0.514 | Friday, 29th Sep 2023 BLPH stock ended at $0.398. This is 4.36% more than the trading day before Thursday, 28th Sep 2023. During the day the stock fluctuated 5.26% from a day low at $0.380 to a day high of $0.400. |
| 90 days | $0.370 | $0.760 | |
| 52 weeks | $0.370 | $12.58 |
Historical Bellerophon Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-09-29 | $0.400 | $0.400 | $0.380 | $0.398 | 22 067 |
| 2023-09-28 | $0.375 | $0.401 | $0.375 | $0.381 | 19 890 |
| 2023-09-27 | $0.385 | $0.404 | $0.370 | $0.375 | 160 425 |
| 2023-09-26 | $0.395 | $0.412 | $0.392 | $0.400 | 37 614 |
| 2023-09-25 | $0.408 | $0.420 | $0.392 | $0.403 | 25 795 |
| 2023-09-22 | $0.420 | $0.420 | $0.407 | $0.408 | 8 833 |
| 2023-09-21 | $0.425 | $0.425 | $0.404 | $0.412 | 61 343 |
| 2023-09-20 | $0.404 | $0.453 | $0.391 | $0.438 | 167 107 |
| 2023-09-19 | $0.413 | $0.413 | $0.373 | $0.388 | 74 986 |
| 2023-09-18 | $0.410 | $0.444 | $0.410 | $0.410 | 24 073 |
| 2023-09-15 | $0.437 | $0.453 | $0.417 | $0.417 | 50 341 |
| 2023-09-14 | $0.457 | $0.459 | $0.437 | $0.453 | 19 491 |
| 2023-09-13 | $0.422 | $0.459 | $0.422 | $0.450 | 56 519 |
| 2023-09-12 | $0.415 | $0.445 | $0.404 | $0.445 | 53 611 |
| 2023-09-11 | $0.445 | $0.447 | $0.400 | $0.438 | 63 180 |
| 2023-09-08 | $0.444 | $0.444 | $0.430 | $0.430 | 19 941 |
| 2023-09-07 | $0.441 | $0.459 | $0.430 | $0.450 | 37 339 |
| 2023-09-06 | $0.431 | $0.459 | $0.430 | $0.450 | 44 366 |
| 2023-09-05 | $0.443 | $0.443 | $0.425 | $0.433 | 20 488 |
| 2023-09-01 | $0.439 | $0.459 | $0.421 | $0.436 | 105 921 |
| 2023-08-31 | $0.451 | $0.470 | $0.423 | $0.431 | 121 117 |
| 2023-08-30 | $0.413 | $0.514 | $0.391 | $0.440 | 280 104 |
| 2023-08-29 | $0.403 | $0.435 | $0.400 | $0.426 | 154 067 |
| 2023-08-28 | $0.400 | $0.405 | $0.390 | $0.405 | 62 854 |
| 2023-08-25 | $0.382 | $0.418 | $0.377 | $0.411 | 221 509 |
About Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
